Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model

International Journal of Experimental Pathology

Volumn 95, Issue 3, 2014, Pages 181-190

  Oberkersch, Roxana ^a   Maccari, Francesca ^b   Bravo, Alicia I ^c   Volpi, Nicola ^b   Gazzaniga, Silvina ^a   Calabrese, Graciela C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Hospital Eva Peron   (Argentina)

Author keywords

Aortic cells; Atherosclerosis; Dermatan sulphate proteoglycans; Extracellular matrix

Indexed keywords

BETA ACTIN; BIGLYCAN; CHONDROITIN 6 SULFATE; CHONDROITIN SULFATE; DECORIN; DERMATAN SULFATE; GALACTOSAMINOGLYCAN; HEPARAN SULFATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PERLECAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERCHOLESTEROLEMIA; IMMUNOCHEMISTRY; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

AORTIC CELLS; ATHEROSCLEROSIS; DERMATAN SULPHATE PROTEOGLYCANS; EXTRACELLULAR MATRIX;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHONDROITIN SULFATE PROTEOGLYCANS; DERMATAN SULFATE; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; GOATS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; PLAQUE, ATHEROSCLEROTIC; RABBITS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900494447     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12072     Document Type: Article

References (41)

1. Anggraeni V.Y., Emoto N., Yagi K. et al. (2011) Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis. Biochem. Biophys. Res. Commun. 406, 36-41.
2. Barfell A., Crumbly A. & Romani A. (2011) Enhanced glucose 6-phosphatase activity in liver of rats exposed to Mg2+-deficient diet. Arch. Biochem. Biophys. 509, 157-163.
3. Calabrese G.C., Alberto M.F., Tubio R. et al. (2004) A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein. Thromb. Res. 113, 43-50.
4. Calabrese G.C., Luczak E.N. & Roux M.E. (2009) Importance of CCL25 in the attraction of T cells and the role of IL-7 on the signaling pathways in intestinal epithelial cells. Immunobiology 214, 403-409.
5. Camejo E.H., Rosengren B., Camejo G., Sartipy P., Fage G. & Bondjers G. (1995) Interferon gamma binds to extracellular matrix chondroitin- sulfate proteoglycans, thus enhancing its cellular response. Arterioscler. Thromb. Vasc. Biol. 15, 1456-1465.
6. Camejo G., Hurt-Camejo E., Wilkund O. & Bondjers G. (1998) Association of lipoproteins with arterial proteoglycans: pathological significance. Atherosclerosis 139, 205-222.
7. Cardoso L.E.M. & Mourao P.A.S. (1994) Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler. Thromb. 14, 115-124.
8. Deepa P.R. & Varalakshmi P. (2005) Atheroprotective effect of exogenous heparin-derivate treatment on aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clin. Chim. Acta 355, 119-130.
9. Evanko S.P., Angello J.C. & Wight T.N. (1999) Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19, 1004-1013.
10. Feferman T., Maiti P.K., Berrih-Aknin S. et al. (2005) Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J. Immunol. 174, 5324-5331.
11. Getachew R., Ballinger M.L., Burch M.L. et al. (2010) PDGF β-Receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology 151, 4356-4367.
12. Groeneveld T.W., Oroszlán M., Owens R.T. et al. (2005) Interactions of extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J. Immunol. 175, 4715-4723.
13. Hachani R., Dab H., Sakly M. et al. (2010) Influence of antagonist sensory and sympathetic nerves on smooth muscle cell differentiation in hypercholesterolemic rat. Auton. Neurosci. 155, 82-90.
14. Hachani R., Dab H., Sakly M. et al. (2011) The profile of extracellular matrix changes in aorta after sympathectomy in hypercholesterolemic rats. Auton. Neurosci. 164, 67-73.
15. Hajra L., Evans A.I., Chen M., Hyduk S.J., Collins Y. & Cybulsky M.I. (2000) The NK-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl Acad. Sci. USA 97, 9052-9057.
16. Hogarth C., Roy A. & Ebert D. (2003) Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 135, 71-81.
17. Joles J.A., Kunter U., Janssen U. et al. (2000) Early mechanism of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J. Am. Soc. Nephrol. 11, 669-683.
18. Kobayashi M., Inoue K., Warabi E., Minami T. & Kodama T. (2005) A simple method of isolating mouse aortic endothelial cells. J. Atheroscler. Thromb. 12, 138-142.
19. Kunjathoor V.V., Chiu D.S., O′Brien K.D., & Le Boeuf R.C. (2002) Accumulation of biglycan and perlecan but not versican, in lesions of murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 462-468.
20. Leta G.C., Moura P.A. & Tovar A.M. (2002) Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins. Biochim. Biophys. Acta 1586, 243-253.
21. Little P.J., Ballinger M.L. & Osman N. (2007) Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc. Health Risk Manag. 3, 117-124.
22. Maccari F., Buzzega D., Galeotti F. & Volpi N. (2011) Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects. Int. Urogynecol. J. 22, 1581-1586.
23. Nakashima Y., Fujji H., Sumiyoshi S., Wight T. & Sueishi K. (2007) Early human atherosclerosis. Accumulation of proteoglycans and lipids in intimal thickenings followed by macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 27, 1159-1165.
24. Raman K.G., Gandley R.E., Rohland J.D., Zenati M.S. & Tzeng E. (2011) Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide. J. Vasc. Surg. 53, 754-763.
25. Rasente R.Y., Egitto P. & Calabrese G.C. (2012) Low molecular mass dermatan sulfate modulates endothelial cells proliferation and migration. Carbohydr. Res. 356, 233-237.
26. Reese S.P., Underwood C.J. & Weiss J.A. (2013) Effects of decorin proteoglycan on fibrillogenesis, ultraestructure, and mechanics of type I collagen gels. Matrix Biol. 32, 414-423.
27. Ross R. (1999) Atherosclerosis an inflammatory disease. N. Engl. J. Med. 340, 115-126.
28. Skalen K., Gustafsson M., Rydberg E.K. et al. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750-754.
29. Tabas I., Williams K.J. & Boré J. (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis. Update and therapeutic implications. Circulation 116, 1832-1844.
30. Tedgui A. & Mallat Z. (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86, 515-581.
31. Theocharis A.D., Theocharis D.A., De Luca G., Hjerpe A. & Karamanos N.K. (2002) Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84, 667-674.
32. Tollefsen D.M. (2010) Vascular dermatan sulfate and heparin cofactor II. Prog. Mol. Biol. Transl. Sci. 93, 351-372.
33. Tovar A.M., Cesar D.C., Leta G.C. & Mourao P.A. (1998) Age-related changes in populations of aortic glycosaminoglycans: species with low affinity for plasma low density lipoproteins, and not species with high affinity are preferentially affected. Arterioscler. Thromb. Vasc. Biol. 18, 604-614.
34. Volpi N. (2010) High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyaluronan disaccharides derivatized with 2-aminoacridone. Anal. Biochem. 397, 12-23.
35. Volpi N. & Maccari F. (2006) Electrophoretic approaches to the analysis of complex polysaccharides. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 834, 1-13.
36. Weng Z., Greenhau J., Salminen W. & Shi Q. (2012) Mechanism for epigallocatechin gallate induced inhibition of drug metabolizing enzymes in rat liver microsomes. Toxicol. Lett. 214, 328-338.
37. Williams K.J. & Tabas I. (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551-561.
38. Young G.D. & Murphy-Ullrich J.E. (2004) Molecular interactions that confer latency to transforming growth factor-beta. J. Biol. Chem. 279, 38032-38039.
39. Zak Z., Gautier T., Dumont L. et al. (2005) Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats. Atherosclerosis 178, 279-286.
40. Zheng P.S., Ven J., Ang L.C. et al. (2004) Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J. 18, 754-756.
41. Zulet M.A., Barber A., Garcin H., Higuere P. & Martínez J.A. (1999) Alterations in carbohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J. Am. Coll. Nutr. 18, 36-42.